EGLN1 and central nervous system cancer: The cell death induced by hypoxia in cells in which PHD2 was silenced (Fig. 7, A–D) was in line with the protective role of PHD2 in gliomas against hypoxia-induced tumor cell death (35) and could well represent a new molecular target for cancer drugs.